108 related articles for article (PubMed ID: 6530462)
1. Determination of the antiallergenic agent, N-[4-(1H-imidazol-1-yl)butyl]-2-(1-methylethyl)-11-oxo-11H- pyrido [2,1-b]quinazoline-8-carboxamide, in plasma by reversed-phase high-performance liquid chromatographic analysis using fluorometric detection.
Strojny N; Puglisi CV; de Silva JA
J Chromatogr; 1984 Dec; 336(2):301-11. PubMed ID: 6530462
[TBL] [Abstract][Full Text] [Related]
2. Determination of the anti-allergenic agent, 2-methoxy-11-oxo-11H-pyrido[2,1-b]quinazoline-8-carboxylic acid, in biological fluids by high-performance liquid chromatography.
Strojny N; de Silva JA
J Chromatogr; 1979 Nov; 179(2):311-21. PubMed ID: 44301
[TBL] [Abstract][Full Text] [Related]
3. Determination of the antiallergenic agent, trans-3-[6-(methylthio)-4-oxo-4H-quinazolin-3-yl]-2-propenoic acid, in plasma by high-performance liquid chromatography.
Pao J; Puglisi CV; de Silva JA
J Chromatogr; 1983 Sep; 276(2):329-40. PubMed ID: 6630382
[TBL] [Abstract][Full Text] [Related]
4. Radioimmunoassay and plasma concentrations of the anti-allergenic agent, 2-methoxy-11-oxo-11-H-pyrido[2,1-b]quinazoline-8-carboxylic acid in man.
Dixon R; Lucek R; Liu YY; Colburn W; Parsonnet M
Res Commun Chem Pathol Pharmacol; 1980 Oct; 30(1):163-70. PubMed ID: 7433765
[TBL] [Abstract][Full Text] [Related]
5. Pyrido[2,1-b]quinazolinecarboxamide derivatives as platelet activating factor antagonists.
Tilley JW; Burghardt B; Burghardt C; Mowles TF; Leinweber FJ; Klevans L; Young R; Hirkaler G; Fahrenholtz K; Zawoiski S
J Med Chem; 1988 Feb; 31(2):466-72. PubMed ID: 3339617
[TBL] [Abstract][Full Text] [Related]
6. Determination of the agonist-antagonist anxiolytic agent 6-(2-chlorophenyl)-4-hydroxy-4H-imidazo[1,5-a]-[1,4]benzodiazepine- 3-carboxamide and its benzophenone carboxylic acid metabolite in plasma by high-performance liquid chromatography.
Puglisi CV; Ferrara FJ; Bekersky I
J Chromatogr; 1987 Jul; 417(2):347-56. PubMed ID: 2888780
[TBL] [Abstract][Full Text] [Related]
7. Determination of diclofensine, an antidepressant agent, and its major metabolites in human plasma by high-performance liquid chromatography with fluorometric detection.
Strojny N; de Silva JA
J Chromatogr; 1985 Jun; 341(2):313-31. PubMed ID: 4030982
[TBL] [Abstract][Full Text] [Related]
8. Determination of (E)-1,2,3,4-tetrahydro-1,1,4,4-tetramethyl-6-(1-methyl-2- phenylethenyl) naphthalene, an antiacne agent, and its phenolic metabolite in plasma by reversed-phase high-performance liquid chromatography.
Puglisi CV; Chen S; Stelling-Ferrara M; Pao J; Bekersky I
J Chromatogr; 1987 Aug; 419():253-62. PubMed ID: 2959673
[TBL] [Abstract][Full Text] [Related]
9. Rapid, high-sensitivity reversed-phase liquid chromatographic assay for 9-chloro-2-(2-furyl) [1,2,4]triazolo[1,5-c]quinazolin-5-imine and its oxo metabolite in plasma using fluorescence detection.
Brubaker WF; Williams ED
J Chromatogr; 1989 Nov; 496(2):377-86. PubMed ID: 2613841
[TBL] [Abstract][Full Text] [Related]
10. Quantitation of flupirtine and its active acetylated metabolite by reversed-phase high-performance liquid chromatography using fluorometric detection.
Narang PK; Tourville JF; Chatterji DC; Gallelli JF
J Chromatogr; 1984 Jan; 305(1):135-43. PubMed ID: 6707137
[TBL] [Abstract][Full Text] [Related]
11. Liquid chromatographic determination of 9-methyl-3-(1H-tetrazol-5-yl)-4H-pyrido[1,2-a]pyrimidin-4-one in human plasma with fluorescence detection.
Cheng H; Pittman KA; Dandekar KA
J Pharm Sci; 1987 Dec; 76(12):918-9. PubMed ID: 2894450
[TBL] [Abstract][Full Text] [Related]
12. Determination of the imidazo quinazoline derivative Ro 13-6438 in biological fluids by high-performance liquid chromatography.
Haefelfinger P; Hess B
J Chromatogr; 1984 Jan; 305(1):153-61. PubMed ID: 6549616
[TBL] [Abstract][Full Text] [Related]
13. Determination of the quinidine analog, 7'-trifluoromethyldihydrocinchonidine-2HCl in plasma and urine by high-performance liquid chromatography.
Pao J; de Silva JA
J Chromatogr; 1980 Nov; 221(1):97-108. PubMed ID: 7451629
[TBL] [Abstract][Full Text] [Related]
14. 11-Oxo-11H-pyrido[2,1-b]quinazoline-8-carboxylic acid, an orally active antiallergy agent.
Schwender CF; Sunday BR; Herzig DJ
J Med Chem; 1979 Jan; 22(1):114-6. PubMed ID: 423174
[TBL] [Abstract][Full Text] [Related]
15. Determination of a new inotropic agent in human plasma by high-performance liquid chromatography.
Hsu SH; Koerper TL; Tomlinson BJ; Miksic JR; Grebow PE
J Chromatogr; 1988 Dec; 459():215-20. PubMed ID: 3243895
[TBL] [Abstract][Full Text] [Related]
16. Quantification of a novel retinoic acid metabolism inhibitor, 4-(1H-imidazol-1-yl)retinoic acid (VN/14-1RA) and other retinoids in rat plasma by liquid chromatography with diode-array detection.
Wu C; Njar V; Brodie A; Borenstein M; Nnane I
J Chromatogr B Analyt Technol Biomed Life Sci; 2004 Oct; 810(2):203-8. PubMed ID: 15380716
[TBL] [Abstract][Full Text] [Related]
17. High-performance liquid chromatographic determination of BRB-I-28, a novel antiarrhythmic agent, in dog plasma and urine.
Chen CL; Lesseley BA; Clarke CR; Roder JD; Sangiah S; Berlin KD; Garrison GL; Scherlag BJ; Lazzara R; Patterson E
J Chromatogr; 1992 Dec; 583(2):274-9. PubMed ID: 1478994
[TBL] [Abstract][Full Text] [Related]
18. High-performance liquid chromatographic determination of tracazolate and its major metabolite in plasma.
Hermes M; Malbica JO
J Pharm Sci; 1984 May; 73(5):667-70. PubMed ID: 6145787
[TBL] [Abstract][Full Text] [Related]
19. Analysis of 2-cyano-1-methyl-3-[4-(4-methyl-6-oxo-1,4,5,6-tetrahydropyridazin-3-yl phenyl]guanidine in dog plasma by liquid-solid extraction and reversed-phase high-performance liquid chromatography.
Pearce JC; Leavens WJ; McDowall RD
J Pharm Sci; 1989 Oct; 78(10):874-6. PubMed ID: 2600797
[TBL] [Abstract][Full Text] [Related]
20. Determination of midazolam (Versed) and its metabolites in plasma by high-performance liquid chromatography.
Puglisi CV; Pao J; Ferrara FJ; de Silva JA
J Chromatogr; 1985 Nov; 344():199-209. PubMed ID: 2935548
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
